Comparison of vitamin D2and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: A systematic review and meta-analysis

American Journal of Clinical Nutrition

Volumn 95, Issue 6, 2012, Pages 1357-1364

  Tripkovic, Laura ^a   Lambert, Helen ^a   Hart, Kathryn ^a   Smith, Colin P ^a   Bucca, Giselda ^a   Penson, Simon ^b   Chope, Gemma ^b   Hyppon̈en, Elina ^c   Berry, Jacqueline ^d   Vieth, Reinhold ^e   Lanham New, Susan ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b CAMPDEN BRI   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; CYTOCHROME P450; ERGOCALCIFEROL; PLACEBO; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN; VITAMIN D;

AGE DISTRIBUTION; DNA POLYMORPHISM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ETHNICITY; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; BLOOD; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG ADMINISTRATION; META ANALYSIS; VITAMIN D DEFICIENCY;

CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; ERGOCALCIFEROLS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84861551708     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.031070     Document Type: Review

References (27)

1. Calman K, ed. Nutrition and bone health with particular reference to calcium and vitamin D: Report of the Subgroup on Bone Health (Working Group on the Nutritional Status of the Population) of the Committee on Medical Aspects of Food and Nutrition Policy. London, United Kingdom: The Stationary Office, 1998.
2. Ross CA, Taylor CL, Yaktime AL, Del Valle HB, eds. Dietary Reference Intakes for calcium and vitamin. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. Washington, DC: National Academies Press, 2010.
3. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008; 88:582S-6S.
4. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998;68:854-8. (Pubitemid 28471068)
5. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008;93:3015-20.
6. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008;93:677-81. (Pubitemid 351398538)
7. Biancuzzo RM, Young A, Bibuld D, Cai MH, Winter MR, Klein EK, Ameri A, Reitz R, Salameh W, Chen TC, et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 2010;91:1621-6.
8. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D-2) as a vitamin supplement. Am J Clin Nutr 2006;84:694-7. (Pubitemid 44715649)
9. Holmberg I, Berlin T, Ewerth S, Bjorkhem I. 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3. Scand J Clin Lab Invest 1986;46:785-90. (Pubitemid 17176648)
10. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85:860-8. (Pubitemid 46393520)
11. Jadad AR,Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
12. Tjellesen L, Hummer L, Christiansen C, Rodbro P. Serum concentration of vitamin-d metabolites during treatment with vitamin-D2 and vitamin- D3 in normal premenopausal women. Bone Miner 1986;1:407-13. (Pubitemid 16010394)
13. Armas LA, Hollis BW, Heaney RP. Vitamin D(2) is much less effective than vitamin D(3) in humans. J Clin EndocrinolMetab 2004;89:5387-91. (Pubitemid 39518413)
14. Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 2009;38:149-53.
15. Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D, Drezner MK. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 2011;96:981-8.
16. Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 2009;45:870-5.
17. Heaney RP, Recker RR, Grote J, Horst RL, Armas LAG. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011;96:E447-52.
18. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010;63:834-40.
19. Review Manager (RevMan). Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
20. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
21. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-72. (Pubitemid 44162310)
22. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem1984;21:81-6. (Pubitemid 14090493)
23. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem 2003;278:38084-93. (Pubitemid 37175340)
24. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004;101:7711-5. (Pubitemid 38658094)
25. Horst RL, Reinhardt TA, Ramberg CF, Koszewski NJ, Napoli JL. 24-Hydroxylation of 1,25dihydroxyergocalciferol - an unambiguous deactivation process. J Biol Chem 1986;261:9250-6. (Pubitemid 17218202)
26. IOM. Dietary Reference Intakes for calcium and vitamin D. Washington, DC: The National Academies Press, 2011.
27. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900.